From October 1, 2023 to December 31, 2023, the company has repurchased 123,562 shares, representing 4.08% for $0.19 million. With this, the company has completed the repurchase of 252,855 shares, representing 8.21% for $0.47 million under the buyback announced on January 31, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.885 USD | -0.26% | +5.90% | +30.90% |
Apr. 23 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
Apr. 10 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.90% | 5.37M | |
-3.45% | 87.17B | |
+2.76% | 40.1B | |
-16.39% | 31.38B | |
+57.86% | 25.12B | |
-16.01% | 15.59B | |
-9.12% | 12B | |
-42.56% | 11.8B | |
-18.10% | 11.8B | |
+6.89% | 8.81B |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.